EAM
Eukles Asset Management’s Ekso Bionics EKSO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-13
| Closed | -$5 | – | 238 |
|
2025
Q1 | $5 | Hold |
13
| – | – | ﹤0.01% | 224 |
|
2024
Q4 | $8 | Hold |
13
| – | – | ﹤0.01% | 229 |
|
2024
Q3 | $15 | Hold |
13
| – | – | ﹤0.01% | 238 |
|
2024
Q2 | $14 | Hold |
13
| – | – | ﹤0.01% | 233 |
|
2024
Q1 | $18 | Hold |
13
| – | – | ﹤0.01% | 231 |
|
2023
Q4 | $33 | Hold |
13
| – | – | ﹤0.01% | 240 |
|
2023
Q3 | $10 | Hold |
13
| – | – | ﹤0.01% | 249 |
|
2023
Q2 | $19 | Hold |
13
| – | – | ﹤0.01% | 243 |
|
2023
Q1 | $21 | Hold |
13
| – | – | ﹤0.01% | 223 |
|
2022
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 208 |
|
2022
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 205 |
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 202 |
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 201 |
|
2021
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 214 |
|
2021
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 213 |
|
2021
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 231 |
|
2021
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 202 |
|
2020
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 157 |
|
2020
Q3 | $0 | Hold |
13
| – | – | ﹤0.01% | 158 |
|
2020
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 156 |
|
2020
Q1 | $0 | Sell |
13
-175
| -93% | – | ﹤0.01% | 151 |
|
2019
Q4 | $0 | Hold |
188
| – | – | ﹤0.01% | 164 |
|
2019
Q3 | $0 | Hold |
188
| – | – | ﹤0.01% | 166 |
|
2019
Q2 | $0 | Hold |
188
| – | – | ﹤0.01% | 170 |
|
2019
Q1 | $0 | Hold |
188
| – | – | ﹤0.01% | 154 |
|
2018
Q4 | $0 | Buy |
+188
| New | – | ﹤0.01% | 151 |
|